Your browser doesn't support javascript.
loading
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer.
Small, E J; Saad, F; Chowdhury, S; Oudard, S; Hadaschik, B A; Graff, J N; Olmos, D; Mainwaring, P N; Lee, J Y; Uemura, H; De Porre, P; Smith, A A; Zhang, K; Lopez-Gitlitz, A; Smith, M R.
Afiliação
  • Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: Eric.Small@ucsf.edu.
  • Saad F; Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, QC, Canada.
  • Chowdhury S; Guy's, King's and St. Thomas' Hospitals, London; Sarah Cannon Research Institute, London, UK.
  • Oudard S; Georges Pompidou Hospital, University René Descartes, Paris, France.
  • Hadaschik BA; University of Duisburg-Essen, Essen; Ruprecht-Karls University Heidelberg, Heidelberg, Germany.
  • Graff JN; VA Portland Health Care System, Portland; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Olmos D; Spanish National Cancer Research Centre (CNIO), Madrid; Hospitales Universitarios Virgen de la Victoria y Regional, Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.
  • Mainwaring PN; Centre for Personalized Nanomedicine, University of Queensland, Brisbane, Australia.
  • Lee JY; St. Mary's Hospital of Catholic University, Seoul, South Korea.
  • Uemura H; Yokohama City University Medical Center, Yokohama, Japan.
  • De Porre P; Janssen Research & Development, Beerse, Belgium.
  • Smith AA; Janssen Research & Development, Spring House, PA.
  • Zhang K; Janssen Research & Development, San Diego, CA.
  • Lopez-Gitlitz A; Janssen Research & Development, Los Angeles, CA.
  • Smith MR; Massachusetts General Hospital Cancer Center, Boston, MA; Harvard Medical School, Boston, MA, USA.
Ann Oncol ; 30(11): 1813-1820, 2019 11 01.
Article em En | MEDLINE | ID: mdl-31560066

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tioidantoínas / Antagonistas de Receptores de Andrógenos / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tioidantoínas / Antagonistas de Receptores de Andrógenos / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2019 Tipo de documento: Article